Metabolic evaluation of first-time and recurrent stone formers
- PMID: 23177631
- PMCID: PMC4052537
- DOI: 10.1016/j.ucl.2012.09.007
Metabolic evaluation of first-time and recurrent stone formers
Abstract
Evaluation of stone formers should include careful attention to medications, past medical history, social history, family history, dietary evaluation, occupation, and laboratory evaluation. Laboratory evaluation requires at least serum chemistries and urinalysis. Twenty-four-hour urine collections are most appropriate for patients with recurrent stones or complex medical histories. However, these collections may be appropriate for some first-time stone formers, including those with comorbidities or large stones. Although twin studies demonstrate that heritability accounts for at least 50% of the kidney stone phenotype, the responsible genes are not clearly identified, and so genetic testing is rarely indicated.
Published by Elsevier Inc.
Similar articles
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones.J Nephrol. 2020 Feb;33(1):101-107. doi: 10.1007/s40620-019-00623-0. Epub 2019 Jun 20. J Nephrol. 2020. PMID: 31222647
-
Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.Kidney Int. 2001 Jun;59(6):2290-8. doi: 10.1046/j.1523-1755.2001.00746.x. Kidney Int. 2001. PMID: 11380833
-
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18. J Urol. 2009. PMID: 19152919
-
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.Scand J Urol. 2020 Dec;54(6):456-462. doi: 10.1080/21681805.2020.1840430. Epub 2020 Nov 13. Scand J Urol. 2020. PMID: 33185135
Cited by
-
Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease.World J Urol. 2017 Sep;35(9):1331-1340. doi: 10.1007/s00345-017-2000-1. Epub 2017 Feb 3. World J Urol. 2017. PMID: 28160089 Review.
-
Quantification of asymptomatic kidney stone burden by computed tomography for predicting future symptomatic stone events.Urology. 2015 Jan;85(1):45-50. doi: 10.1016/j.urology.2014.08.031. Epub 2014 Oct 22. Urology. 2015. PMID: 25440821 Free PMC article.
-
Epidemiology of stone disease across the world.World J Urol. 2017 Sep;35(9):1301-1320. doi: 10.1007/s00345-017-2008-6. Epub 2017 Feb 17. World J Urol. 2017. PMID: 28213860 Review.
-
Outcomes and rates of dissolution therapy for uric acid stones.J Nephrol. 2022 Mar;35(2):665-669. doi: 10.1007/s40620-021-01094-y. Epub 2021 Jun 25. J Nephrol. 2022. PMID: 34170507
-
Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement.J Nephrol. 2016 Dec;29(6):715-734. doi: 10.1007/s40620-016-0329-y. Epub 2016 Jul 25. J Nephrol. 2016. PMID: 27456839 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous